Skip to content

Medpace Voice

Category: Clinical Development

Clinical Development

A New Paradigm in Infectious Diseases Treatment & Prophylaxis Shaped by the Current Pandemic

  • June 2, 2021

The COVID-19 pandemic will end, or as any pandemic in the past, will lose its momentum. Yet, the precedents and the new paradigms formed in…

Clinical Development

Webinar: Revisiting and Rebuilding Clinical Development of Drugs for Antimicrobial Resistance – Lessons Learned During the COVID-19 Pandemic

  • April 21, 2021

Join AMR experts from Medpace, IHMA, and GARDP as they discuss how we can use the momentum from the pandemic to rethink, rebuild and revitalize…

Clinical Development

Chronic Kidney Disease & Its Impact on Clinical Development – Part 2

  • March 25, 2021

This post is the second of a three-part blog series. In Part 2, we take a look at the biomarkers for chronic kidney disease.

Clinical Development

Wearable Biosensors are Changing the Future of Clinical Trials

  • March 9, 2021

Clinical trialists have moved to an older trial model requiring less patient mobility and preferably centered at home, but now with innovative next-gen remote biosensing…

Clinical Development

Partnership with Greenleaf Enhances Strategic Regulatory Affairs Capabilities

  • February 2, 2021

"This partnership strengthens our global Regulatory Affairs offering and allows us to expand our strategic capabilities to support our Sponsors’ programs.” - Jon Isaacsohn, MD,…

Clinical Development

Chronic Kidney Disease & Its Impact on Clinical Development – Part 1

  • January 18, 2021

Recently, medical and operational experts from our nephrology team presented a webinar on Chronic Kidney Disease (CKD). Over the next several weeks, we will build…

Clinical Development

Medpace Clinical Pharmacology Unit working with HiFiBIO Therapeutics on a SARS-CoV-2 ID-neutralizing antibody for the treatment and prevention of COV19

  • October 29, 2020

In a recent news release, HiFiBiO Therapeutics announced the successful completion of the first cohort of the Phase I study (NCT04590430) of HFB30132 which was…

Clinical Development

New White Paper: The Intersection of Rare Diseases and Advanced Therapies and What it Means for Clinical Development

  • October 22, 2020

Read the press release for the latest whitepaper on advanced therapies and rare diseases published by Xtalks and Medpace.

Clinical Development

Spotlight on Rare Disease Clinical Development

  • August 27, 2020

There is a lot of uncertainty in the world right now, but one thing for certain is that rare disease and orphan indication clinical research…

Clinical Development

Webinar: How A Deeper Understanding of Chronic Kidney Disease Is Impacting Clinical Development

  • August 20, 2020

Medpace’s experts will be discussing important topics from both a medical and operational perspective.